期刊文献+

雌激素及其代谢产物对去势低氧肺动脉高压大鼠烷烃单加氧酶和低氧诱导因子-1α表达的影响 被引量:7

Effect of Estradiol and its Metabolite on Hypoxic Induced Factor-1α and Alkane Hydroxylase in Experimental Rats With Ovariectomy and Hypoxic Pulmonary Hypertension
下载PDF
导出
摘要 目的:探讨17β-雌二醇(E2)及2甲氧基雌二醇(2ME)对去势低氧肺动脉高压大鼠模型中烷烃单加氧酶(AIkB)和低氧诱导因子-1α(HIF-1α)的影响。方法:选6~7周龄雌性sD大鼠60只,去势手后采用随机数字表法将大鼠随机分为6组:常氧组(D=10),常氧+E2组(n=1O),常氧+2ME组(n=10),低氧组(n=10),低氧+E2组(n=10),低氧+2ME组(n=10)。低氧组持续低氧(24h,8周);2ME组自造模之日起,每日皮下注射2ME(240μg/kg);E2组每日皮下注射E2(20μg/kg)。连续饲养8周,以建讧低氧性肺动脉高压模型。测量平均肺动脉压(mPAP)后放血处死大鼠,观察有心室肥厚指数(RVHI),苏木素-伊红(HE)染色观察肺小动脉重构情况。采用免疫蛋白印迹法、反转录聚合酶链反应(RT-PCR)测定AIkB、HIF-1α的表达水平。结果:与常氧组比较,低氧组大鼠肺小动脉管壁增厚管腔变窄明显,mPAP、RVHI均显著升高,低氧+E2组和低氧+2ME组j:述形态学改变相对较轻,mPAP、RVHI均显著高于常氧组,且低氧+E2组和低氧+2ME组间无明显差异,常氧+E2组和常氧+2ME组肺小血管形态学无明显变化。HIF-1d表达水平在低氧组显著高于常氰组,低氧+E2组、低氧+2ME组亦升高,升高幅度不及低氧组,常氧+E2组、常氧+2ME组无明显变化。AlkB表达水平在低氧细显著低于常氧组,低氧+E2组、低氧+2ME组亦降低,降低幅度不及低氧组,常氧+E2组、常氧+2ME组无明显变化。结论:E2和2ME可能通过卜调低氧性肺动脉高压大鼠肺组织AlkB的表达,降低HIF-1α表达,进而缓解肺动脉高乐。 Objective: To explore the effects of 17β-estrogen (E2) and 2-methoxyestradiol (2ME) on hypoxic induced factor-1α (HIF-1α) and alkane hydroxylase (AlkB) in experimental rats with ovariectomy and hypoxic pulmonary hypertension. Methods: A total of 60 healthy female SD rats with castrated surgery were randomly divided into 6 groups: (1) Routine oxygen group, (2) Routine oxygen + E2 group, the rats received subcutaneous injection orE2 (20 μg/kg·d), (3) Routine oxygen + 2ME group, the rats received 2ME (240 μg/kgod) and (4) Hypoxia group, (5) Hypoxia + E2 group, (6) Hypoxia + 2ME group, n=10 in each group and all animals were treated for 8 weeks to establish the hypoxic pulmonary hypertension model. The mean pulmonary artery pressure (mPAP) was measured after bloodletting, right ventricle hypertrophy index (RVHI) was calculated and small pulmonary arteryremodeling was observed by HE staining. The expression level of HIF-1α and AIkB were examined by RT-PCR and Western blot analysis. Results: Compared with Routine oxygen group, the rats in Hypoxia group had obviously thickened small pulmonary artery wall with narrowed lumen, increased rnPAP and RVHI; the above changes in Hypoxia + E2 and Hypoxia + 2ME groups were relatively smaller, their mPAP and RVHI were higher than Routine oxygen group, while mPAP and RVHI were similar between Hypoxia + E2 and Hypoxia + 2ME groups. There were no real morphological changes in small pulmonary vessels in Routine oxygen + E2 and Routine oxygen + 2ME groups. The HIF-1α expression was obviously elevated in Hypoxia group than Routine oxygen group, while the elevation was less in Hypoxia + E2 and Hypoxia + 2ME groups. HIF-1α expression had no real changes in Routine oxygen+E2 and Routine oxygen + 2ME groups. The AlkB expression was obviously reduced in Hypoxia group than Routine oxygen group, while the reduction was less in Hypoxia + E2 and Hypoxia + 2ME groups. AIkB expression had no real changes in Routine oxygen + E2 and Routine oxygen + 2ME groups. Conclusion: Estradiol E2 and 2ME could remit pulmonary hypertension which might be via up-regulating AlkB expression and down-regulating HIF- 1α expression in experimental rats with hypoxic pulmonary hypertension.
出处 《中国循环杂志》 CSCD 北大核心 2015年第9期884-888,共5页 Chinese Circulation Journal
基金 河北省自然科学基金(H2013206403)
关键词 肺动脉高压 缺氧 17Β-雌二醇 2甲氧基雌二醇 低氧诱导因子-1Α Pulmonary hypertension Anoxia 17β -estrogen 2-methoxyestradiol Hypoxia induced factor-1
  • 相关文献

参考文献13

  • 1朱锋,董琳,熊长明.读2009欧洲心脏病学会肺动脉高压诊断和治疗指南解析肺动脉高压新分类[J].中国循环杂志,2010,25(1):74-75. 被引量:31
  • 2Park J. STAT3 inhibits the degradation of HIF-1α by pVHL- mediated ubiquitlnation. Exp Mol Med, 2008, 40: 479-485.
  • 3Lakham NJ, Sarkar MA, Venitz J, et al. 2-methoxyeslracliol, a promising antieaneer drug. Pharmaeolherapy, 2003, 23: 165-172.
  • 4Miyamoto N, Mandai M, Takagi H, et al. Contrasting effect of estrogen on VEGF induction under different oxygen status and it s role in murine ROE Ophthalmol Vis Sci, 2002, 43: 2007-2014.
  • 5Lippert C, Seeger H, Mueck AO, et al. The effects of A-ring and D-ring metaboliles of estradiol on the proliferation of vascular endothelial cells. Life Sci, 2000, 67: 1653-1658.
  • 6Dupont J, Karas M, LeRoith D. The potentiation of estrogen of insulin like growth factor Ⅰ action in MCF-7 haman cancer cells includes cell cycle components. J Bio Chem, 2000, 275: 35893-35900.
  • 7Suzuma I, Mandai M, Takagi H, et al. 17-Eslradiol increases VEGF receptor-2 and promotes DNA synthesis in relinnl microvascular endothelial cells. Invest Opthahnol Vis Sci, 1999, 40: 2122-2129.
  • 8Geraldes P, Sirois MG, Bernatchcz PN, et el. Estrogen regulation of endothelial and smooth muscle cell migration and proliferationw. Role of p38 and p42/44 milogen-aetivate protein kinase. Arterioseler Thromb Vase Biol, 2002, 22: 1585-1590.
  • 9Alsharnoubi JM, Odhmd HH, Saugstad OD. Nicotine does not influence NF-κB activity in neonalal mice reoxygenated with room-air or 100% oxygen. J Matern Fetal Neonatal Med, 2012, 25: 2102-2105.
  • 10郑泉,邓华君,袁雅冬.雌激素及其代谢产物与肺动脉高压的相关性研究[J].中国循环杂志,2015,30(2):199-200. 被引量:6

二级参考文献29

  • 1孙波 刘文利.右心导管测定大鼠肺动脉压的实验方法[J].中国医学科学院学报,1984,6:465-465.
  • 2Galie N, Hoeper MM, Humbert M, et al. Guidelines for the diagnosis and treatment of pulmonary hypertension : The Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur Heart J, 2009,30:2493-2537.
  • 3Simonneau G, Galie N, Rubin LJ,et al. Clinical classification of pulmonary hypertension. J Am Coll Cardiol, 2004,43:5S-12S.
  • 4Fishman AP. Clinical classification of pulmonary hypertension. Clin Chest Med, 2001,22:385-391.
  • 5Trewick SC, Henshaw TF, Hausinger RP, et al. Oxidative demethylation by Eseheriehia eoli AlkB directly reverts DNA base damage. Nature, 2002, 419: 174-178.
  • 6Aas PA, Otterlel M, Falnes PO, et al. Human and bacterial oxidative demethylases repair alkylation damage in both RNA and DNA. Nature, 2003, 421 : 859-863.
  • 7Badesch DB, Champion HC, Sanchez MA, et al. Diagnosis and assessment of pulmonary arterial hypertension. J Am Coll Cardiol, 2009, 54 : S55-S66.
  • 8Kataoka H, Yamamoto Y, Sekiguchi M. A new gene (alkB) of Eseheriehia eoli that controls sensitivity to methyl methane sulfonate. J Bacteriol, 1983, 153: 1301-1307.
  • 9Kim YN, Wiepz GJ, Guadarrama AG, et al. Epidermal growth factor-stimulated tyrosine phosphorylation of caveolin-1. Enhanced caveolin-1 tyrosine phosphorylation following aberrant epidermal growth factor receptor status. J Biol Chem, 2000, 275: 7481- 7491.
  • 10Manalo DJ, Rowan A, Lavoie T, et al. Transcriptional regulation of vascular endothelial cell responses to hypoxia by HIF-1. Blood, 2005, 105: 659-669.

共引文献38

同被引文献77

  • 1慢性阻塞性肺疾病诊治指南(2007年修订版)[J].中华内科杂志,2007,46(3):254-261. 被引量:1795
  • 2代红,王春茂.血清缺氧诱导因子.1A及血管内皮生长因子与高原肺动脉高压的关系[J].医药前沿,2014,(16):173.
  • 3Lau EM, Tamura Y, Mcgoon MD, et al. The 2015 ESC/ ERS guidelines for the diagnosis and treatment of pulmo- nary hypertensiom a practical chronicle of progress[J]. Euro Respirat J, 2015,46 (4) : 879-882.
  • 4Bienertova-Vasku J, Novak J, Vasku A. MicroRNAs in pulmonary arterial hypertension: pathogenesis, diagnosis and treatment[J]. J Am Soe H ypertens, 2015,9 ( 3 ) : 221- 234.
  • 5Ball MK,Waypa GB, Mungai PT, et al. Regulation of hy- poxia-induced pulmonary hypertension by vascular smooth muscle hypoxia-inducible factor-lalpha[J]. Am J Respir Crit Care Med,2014(189):314-524.
  • 6Shimoda LA, Semenza GL. HIF and the lung role of hy- poxia-inducible factors in pulmonary development and dis- ease[J]. Am J Respir Crit Care Med, 2011,183 (2) : 152- 156.
  • 7Yates LA,Norbury CJ,G~lbert RJ. The long and short of microRNA[J]. Cell, 2013,153 (3) : 516-519.
  • 8Li S,Liu L,Zhuang X,et al. MicroRNAs inhibit the trans-lation of target mRNAs on the endoplasrnic reticulum in Arabidopsis[J]. Cell, 2013,153 (3) : 562-574.
  • 9Berezikov E,Guryev V, Van De Belt J, et al. Phylogenetic shadowing and computational identification of human mi- croRNA genes[J]. Cell, 2005,120 ( 1 ) : 21-24.
  • 10Semenza GL,Wang GL. A nuclear factor induced by hy- poxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for tran- scriptional activation[J]. MO1 Cell Biol, 1992, 12 (12) : 5447-5454.

引证文献7

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部